NEW YORK--(BUSINESS WIRE)--IPG Mediabrands, the media holding company within the Interpublic Group of Companies (NYSE: IPG), today announced the appointment of Stacy DeRiso as Brand President of Initiative, leading the agency globally. Over the last few years, Stacy has been instrumental in helping to shape Initiative's vision and strategy, particularly through the "Fame & Flow" framework. She has a proven track record, deep understanding of Initiative and its clients, and a strong collabor.

Netflix continues to deliver outsized growth thanks to its stable streaming share, robust performance metrics, and expanding advertising monetization opportunities. The same has been observed in the reiterated FY2025 guidance, well-supported by the rich FQ1'25 outperformance, with further double beat performances likely. On the other hand, given the decelerating growth profile and the risks arising from the speculative 100% movie tariff, it is apparent that NFLX is overly expensive here.

The partnership advances Sanas' broader mission to break communication barriers and create a more understanding world The partnership advances Sanas' broader mission to break communication barriers and create a more understanding world

SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight Technologies, Inc. (NYSE: KEYS) announced that it helped AMD accelerate the testing of electrical compliance for PCI Express® (PCIe) specification for pre-production AMD server CPUs. By providing early access to beta software, Keysight enabled AMD to develop and test a PCI Express technology-capable server motherboard operating at up to 64 GT/s. The server was shown for the first time at the PCI-SIG Developer's Conference June 11-12 in Santa Clara,.

SANTA MONICA, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Super League Enterprise, Inc. (Nasdaq: SLE) (the “Company”), a leader in engaging audiences through playable media, content, and experiences within mobile games and the world's largest immersive platforms, announced today a reverse stock split of its issued and outstanding shares of common stock, par value $0.001 per share (“Common Stock”), at a ratio of 1-for-40 (the “Reverse Split”).

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQ: DMRC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.

GEHC expands its bkPortfolio with the AI-powered bkActiv S Series to advance ultrasound-guided procedures.

The average of price targets set by Wall Street analysts indicates a potential upside of 44.4% in Paysign (PAYS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Active management and a 1.44% expense ratio boost PLTY's income potential, but single-stock focus and market swings demand careful oversight.

The mean of analysts' price targets for Semtech (SMTC) points to a 40% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 25.5% upside potential for C3.ai (AI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 282.7% upside potential for Rapt Therapeutics (RAPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The merger creates the world's second-largest steel maker.

IBM Corp. (IBM) shares rise to a new all-time high after the company introduced new agentic A.I. software. Diane King Hall joins Nicole Petallides to dive into IBM's move after BoFA analysts raised its price target to $320.

SEATTLE, WA / ACCESS Newswire / June 18, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced that it has entered into securities purchase agreements with certain healthcare-focused and institutional investors to purchase (i) 2,465,000 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 12,325,000 shares of its common stock (the "Common Warrants") at a purchase price of $3.25 per share and associated Common Warrants in a registered direct offering …

NEW YORK--(BUSINESS WIRE)--Ares Management has acquired a minority stake in the France SailGP Team, joining a consortium of investors that includes football star Kylian Mbappé.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.